Literature DB >> 10433566

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia.

B Byl1, P Clevenbergh, F Jacobs, M J Struelens, F Zech, A Kentos, J P Thys.   

Abstract

Antimicrobial therapy for 428 episodes of bacteremia in an 850-bed university hospital was prospectively evaluated for 1 year to measure the impact of two factors--blood culture results and the therapy chosen by infectious diseases specialists (IDSs)--on quality of treatment and outcome. Initial shock, a simplified acute physiology score of >15, and inappropriateness of the empirical treatment were independently associated with increased mortality. Empirical treatment was appropriate in 63% of the episodes. This proportion reached 78% for the episodes treated by IDSs, compared with 54% for the others (P < .001). After availability of blood culture results, the proportion of appropriate treatments increased to 94%, with 97% for IDS-treated patients and 89% for other patients (P = .008). IDSs more frequently shifted to oral antibiotics and used fewer broad-spectrum drugs. This study underlines the impact of blood culture results and of IDSs on the prescription of appropriate treatment for bacteremia and on the better use of antimicrobial drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433566     DOI: 10.1086/520182

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  60 in total

1.  The emerging power of molecular diagnostics: towards improved management of life-threatening infection.

Authors:  M J Struelens; R de Mendonça
Journal:  Intensive Care Med       Date:  2001-10-30       Impact factor: 17.440

2.  Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures.

Authors:  N Maes; J Magdalena; S Rottiers; Y De Gheldre; M J Struelens
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 3.  Infections in neurosurgery: using laboratory data to plan optimal treatment strategies.

Authors:  Erwin M Brown
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Frequency of low-level bacteremia in children from birth to fifteen years of age.

Authors:  J A Kellogg; J P Manzella; D A Bankert
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Clinical impact of a PCR assay for identification of Staphylococcus aureus and determination of methicillin resistance directly from blood cultures.

Authors:  M Hallin; N Maes; B Byl; F Jacobs; Y De Gheldre; M J Struelens
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

6.  Influence of microbiological reports on physician's choice of antimicrobial treatment for susceptible pathogens.

Authors:  J Cobo; J Oliva; J Sanz; J M Aguado; Jose L Del Pozo; J del Pozo; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

7.  Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.

Authors:  S Diamantis; C Rioux; C Bonnal; É Farfour; E Papy; A Andremont; P Yeni; É Bouvet; J-C Lucet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-02       Impact factor: 3.267

8.  Clinical and economic impact of rapid reporting of bacterial identification and antimicrobial susceptibility results of the most frequently processed specimen types.

Authors:  A Galar; J R Yuste; M Espinosa; F Guillén-Grima; S Hernáez-Crespo; J Leiva
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-08       Impact factor: 3.267

Review 9.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

10.  Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center.

Authors:  E Velasco; R Byington; C A S Martins; M Schirmer; L M C Dias; V M S C Gonçalves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.